Stay updated on KN035 Anti-PD-L1 Clinical Trial
Sign up to get notified when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.

Latest updates to the KN035 Anti-PD-L1 Clinical Trial page
- Check6 days agoChange DetectedThe page revision tag changed from v3.5.4 to v3.5.5, indicating a newer revision of the page content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNo textual changes are detected in the provided change set for this page. The page content remains as shown in the current context.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor deployment update to the page or platform with no visible content changes.SummaryDifference0.1%

- Check35 days agoChange DetectedA new publication citation was added under Publications. It references a 2024 Oncologist article about envafolimab (PD-L1 antibody) in advanced solid tumors.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating an update to the page's version in the site's revision history. This reflects an administrative update to the page metadata rather than substantive content changes.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision label updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

Stay in the know with updates to KN035 Anti-PD-L1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.